Funder: Food and Drug Administration (FDA)
Due Dates: Projected July 2025
Funding Amounts: Up to $400,000 per award; typical duration not specified
Summary: Supports innovative natural history studies to accelerate medical product development for rare diseases with unmet needs.
Key Information: Forecasted opportunity; all dates and details are subject to change.